07.01.2014 07.01.2014
A just-announced advisory committee set to meet in February 2014 may bring US regulators one step closer to alleviating a major shortage of asthma medication that resulted from the implementation of long-planned environmental regulations banning certain types of aerosol propellants.

11.12.2013 11.12.2013
Inhaler Dose Counters Reduce Visits to ED - Dose counters on rescue inhalers reduced emergency department visits, a real-world observational study showed.

31.10.2012 31.10.2012
Novartis has submitted the once-daily inhaled combination drug QVA149 for approval in Europe for the treatment of COPD in adults. This triggered a $5 million milestone for licensee Vectura Group, founded and backed by British biotech entrepreneur Sir Chris Evans. QVA149 combines glycopyrronium bromide (licensed from Vectura and its co-development partner Sosei) and indacaterol with Novartis' Breezhaler single-dose dry powder inhaler (SDDPI).

23.05.2012 23.05.2012

Boehringer Ingelheim's once-daily bronchodilator olodaterol* successfully completes Phase II clinical trial program in COPD. INGELHEIM, Germany--Data presented today at the 2012 Annual Meeting of the American Thoracic Society completes the olodaterol monotherapy Phase II clinical trial program in patients with chronic obstructive pulmonary disease (COPD). This Phase II study compared the efficacy of once-daily versus twice-daily olodaterol, delivered via the Respimat® Soft Mist™ Inhaler (SMI) device.

27.04.2012 27.04.2012
23-27.04.2012 in Moscow there was the XIX Russian National Congress "Man and medicine." The Congress was dedicated to the 180th anniversary of one of the greatest figures of national medicine - a prominent Russian therapist, Sergey Petrovich Botkin. He was the best personification of a productive and mutually supportive alliance of medicine and physiology.

27.04.2012 27.04.2012
25-27.04.2012 in Tomsk there was organized the 15-th International Specialized Exhibition and Fair "Medicine. Healthcare. Pharmaceuticals - 2012 ". Location: Exhibition Hall of Tomsk International Business Center "Technopark"

27.04.2012 27.04.2012
25-27.04.2012 in St. Petersburg there was hosted the St. Petersburg International Forum IPhEB.

24.04.2012 24.04.2012
International Nasal and Buccal Drug Delivery Conference  was held in London on  23 – 24 April 2012.

23.04.2012 23.04.2012
21.04.2012 at the territory of "Pharmaceutical Factory of St. Petersburg" there was organized voluntary Saturday work. The staff of our company was occupied with landscaping and cleaning the factory premises and area.

14.04.2012 14.04.2012
A congress of Ural Federal District pulmonologists took place in Yekaterinburg. It was dedicated to Sergey Petrovich Botkin supported by the Office of the Plenipotentiary Representative of RF President in the Ural Federal District and the Ministry of Healthcare of Sverdlovsk region. The conference highlighted the practical problems of modern pulmonology, allergology, pediatric pulmonology, information technology in pulmonology. OAO "Pharmaceutical Factory of St. Petersburg" was presented in the Congress by brand director for pulmonary drug Margarita Zyuzina.

News 11 - 20 из 49
Начало | Пред. | 1 2 3 4 5 | След. | Конец